RSS-Feed abonnieren

DOI: 10.1055/s-0043-1775554
Is There a Genetic Relationship between Acute Lymphoblastic Leukemia and Meningioma? A Case Report of the Analyses of Three Genes
Há alguma relação genética entre leucemia linfoblástica aguda e meningioma? Relato de caso das análises de três genesAuthors

Abstract
Meningiomas are the most common tumors of the central nervous system, and they are generally slow growing and benign. Acute lymphoblastic leukemia (ALL) is a life-threatening ltype of cancer that involves the accumulation of peripheral blood vessels and immature cells in the bone marrow. Genetic mutations play an important role in the etiology of both diseases. Therefore, in the case herein presented, we investigated the meningioma 1 (MN1), nucleophosmin 1 (NPM1), and Wilms tumor 1 (WT1) genes for possible genetic mutations. A 27-year-old female with a chief complaint of headache and history of lllALL presented with a mass in the left frontal lobe. The pathological analysis revealed a fibroblastic meningioma. However, the three genes were found to be normal in the analysis. In light of these findings, we did not encounter any evidence of a genetic relationship between meningioma and ALL in the present study.
Resumo
Os meningiomas são os tumores mais comuns do sistema nervoso central e geralmente apresentam crescimento lento e são benignos. A leucemia linfoblástica aguda (LLA) é um tipo de câncer com risco de vida que envolve o acúmulo de vasos sanguíneos periféricos e células imaturas na medula óssea. As mutações genéticas desempenham um papel importante na etiologia de ambas as doenças. Portanto, no caso aqui apresentado, investigamos os genes do meningioma 1 (MN1), nucleofosmina 1 (NPM1) e tumor de Wilms 1 (WT1) para possíveis mutações genéticas. Uma mulher de 27 anos com queixa principal de cefaleia e história de LLL apresentou uma massa no lobo frontal esquerdo. A análise anatomopatológica revelou um meningioma fibroblástico. No entanto, os três genes foram considerados normais na análise. À luz desses achados, não encontramos nenhuma evidência de relação genética entre meningioma e LLA no presente estudo.
Publikationsverlauf
Eingereicht: 11. Dezember 2020
Angenommen: 22. Februar 2021
Artikel online veröffentlicht:
29. September 2023
© 2023. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Galani V, Lampri E, Varouktsi A, Alexiou G, Mitselou A, Kyritsis AP. Genetic and epigenetic alterations in meningiomas. Clin Neurol Neurosurg 2017; 158: 119-125
- 2 Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98 (07) 1337-1354
- 3 Pritchard-Jones K, Fleming S, Davidson D. et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990; 346 (6280) 194-197
- 4 Lekanne Deprez RH, Riegman PH, Groen NA. et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 1995; 10 (08) 1521-1528
- 5 Carella C, Bonten J, Sirma S. et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 2007; 21 (08) 1679-1690
- 6 Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 2006; 15 (Spec No 2): R196-R201
- 7 Cilloni D, Renneville A, Hermitte F. et al. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. J Clin Oncol 2009; 27 (31) 5195-5201
- 8 Okuwaki M, Matsumoto K, Tsujimoto M, Nagata K. Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett 2001; 506 (03) 272-276
- 9 Carturan S, Petiti J, Rosso V. et al. Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection. Oncotarget 2016; 7 (45) 74082-74096
- 10 Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am 2015; 62 (01) 47-60
- 11 Mullighan CG, Miller CB, Radtke I. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453 (7191) 110-114
- 12 Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005; 23 (26) 6306-6315
- 13 Swaminathan V, Kishore AH, Febitha KK, Kundu TK. Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription. Mol Cell Biol 2005; 25 (17) 7534-7545